NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Down 34.4% in March

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) was the target of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 134,000 shares, a decline of 34.4% from the February 28th total of 204,300 shares. Currently, 0.5% of the shares of the company are short sold. Based on an average daily trading volume, of 212,400 shares, the days-to-cover ratio is currently 0.6 days.

NeuroOne Medical Technologies Stock Down 1.1 %

NASDAQ:NMTC traded down $0.01 during mid-day trading on Monday, hitting $0.85. 73,253 shares of the company traded hands, compared to its average volume of 146,700. NeuroOne Medical Technologies has a one year low of $0.55 and a one year high of $1.39. The stock’s fifty day moving average price is $1.07 and its 200-day moving average price is $0.94. The firm has a market cap of $26.24 million, a price-to-earnings ratio of -3.27 and a beta of 0.48.

NeuroOne Medical Technologies (NASDAQ:NMTC) last released its earnings results on Wednesday, February 12th. The company reported $0.06 earnings per share for the quarter. NeuroOne Medical Technologies had a negative return on equity of 270.70% and a negative net margin of 82.17%.

Institutional Investors Weigh In On NeuroOne Medical Technologies

Several hedge funds have recently bought and sold shares of NMTC. Jane Street Group LLC purchased a new stake in NeuroOne Medical Technologies during the 4th quarter valued at about $33,000. Geode Capital Management LLC increased its stake in NeuroOne Medical Technologies by 9.8% in the fourth quarter. Geode Capital Management LLC now owns 311,659 shares of the company’s stock valued at $257,000 after purchasing an additional 27,804 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of NeuroOne Medical Technologies in the 3rd quarter valued at about $26,000. Hedge funds and other institutional investors own 16.07% of the company’s stock.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.